National Differences in Requirements for Ethical and Competent Authority Approval for a Multinational Vaccine Trial under the EU Directive 2001/20/EC
Obtaining approval for a multinational vaccine trial from an ethics committee and the national competent authority of different Member States of the European Union (EU) is challenging under clinical trial Directive 2001/20/EC because of the differences in the implementation of the directive in nati...
Main Authors: | Eva van Doorn, Eelko Hak, Bob Wilffert |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-04-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | http://www.mdpi.com/2076-393X/3/2/263 |
Similar Items
-
GCP inspections in Germany and Europe following the implementation of the Directive 2001/20/EC
by: Hundt, Ferdinand, et al.
Published: (2009-03-01) -
An audit of the approval letters issued by Drugs Controller General of India to Ethics Committees in India
by: Shruti S Bhide, et al.
Published: (2016-01-01) -
Scientific Opinion on a notification (reference C/NL/09/02) for the placing on the market of the genetically modified carnation IFD‐26407‐2 with a modified colour, for import of cut flowers for ornamental use, under Part C of Directive 2001/18/EC from Florigene
by: EFSA Panel on Genetically Modified Organisms (GMO)
Published: (2014-12-01) -
Scientific Opinion on a notification (reference C/NL/09/01) for the placing on the market of the genetically modified carnation IFD‐25958‐3 with a modified colour, for import of cut flowers for ornamental use, under Part C of Directive 2001/18/EC from Florigene
by: EFSA Panel on Genetically Modified Organisms (GMO)
Published: (2014-12-01) -
Fragility of randomized trials supporting cancer drug approvals stratified by approval pathway and review designations
by: Brooke E. Wilson, et al.
Published: (2021-08-01)